Media Advisory: Lunit at RSNA 2018

Media Advisory: Lunit at RSNA 2018

Lunit INSIGHT for Mammography to be revealed

Lunit, a medical AI software company, will be returning to the 104th Radiological Society of North America (RSNA) this year, launching its new solution for mammography—Lunit INSIGHT for Mammography.

Lunit INSIGHT for Mammography is a diagnostic support tool that accurately detects malignant lesions suspicious of breast cancer with 97% accuracy. It provides location information of detected lesions in heatmaps and shows abnormality scores that reflect the probability of malignancy. Expected to clear FDA/CE approval for clinical use by late 2019, Lunit INSIGHT for Mammography will open to the public for a free online demo on 19 November.

Lunit INSIGHT for Chest Radiography will also be showcased. Since being launched during last year’s RSNA, it has been tested in more than 1.5 million cases from more than 70 countries. Boasting an unprecedented accuracy level of 97-99%, it detects major chest abnormalities including nodules, consolidation, pneumothorax, and etc. The CAD-based solution is also being integrated into the worklist for prioritization, in which positive cases may be read first in order to decrease turnaround time and increase overall reading productivity.

Other products currently in research will also be available for demonstrations.

  • Where: Booth #7561 North
  • When: 25-30 Nov 2018, 10:00 am to 5:00 pm daily (except 30 Nov: until 2:00 pm)

On Wednesday, 28 Nov. 12:00 pm, Brandon Suh, the new CEO of Lunit, will be on stage at Machine Learning Theater to give a presentation. Titled, “From AI-powered Diagnostic Support Tools to Imaging Biomarkers: Aiming Beyond Human-Level Accuracy,” Brandon will provide an overview of Lunit’s recent achievements and future developments.

A press conference at Lunit booth (#7561 North) is also scheduled after the presentation, at 1:00 pm, 28 Nov 2018. Please send an email to media@lunit.io if you’d like to rsvp for the press conference and/or if you’d like to schedule a meeting with us.

Click here to visit Lunit Virtual Press Office at RSNA

 

For more information, please contact:

Jussarang Lee, Communications Manager

julee@lunit.io

Jussarang Lee Communications Manager
About Lunit

Perfecting Intelligence. Transforming Medicine.

Lunit, abbreviated from “learning unit,” is a medical AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. It has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit
6th floor, 175 Yeoksam-ro, Gangnam-gu,
Seoul, South Korea

서울시 강남구 역삼로 175 6층 (역삼동, 현승빌딩)